Delivery Order SPE2DB25D3020-SPE2DB25FWKRN
- Not listed
- The Defense Logistics Agency awarded a $1,877.45 delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) on June 16, 2025, with a completion date of June 17, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $3,811.64 delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-unit supply) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be delivered to the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,536.88 delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 MG tablets (30-count units) with a firm fixed price contract type. This delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a child delivery...
- The Defense Logistics Agency awarded a $3,536.88 delivery order to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count units) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by June 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of XCOPRI 50 MG tablets (30-count packages) valued at $7,622.85. This firm fixed-price delivery order represents a non-competitive award and carries an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,883.74 to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count package) on September 12, 2025, with completion targeted for September 15, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,937.76 to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count supply) with a firm fixed price structure. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside procurement. Performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's $999.9...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for XCOPRI 150 mg tablets in a quantity of 30s. This competitively awarded, non-set-aside contract has a firm fixed price of $1,548.96 with an ultimate completion date of June 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,874.46 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed-price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,768.44 for XCOPRI 150 mg tablets (30-count units) with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKRNDelivery Order
The Defense Logistics Agency awarded a $2,357.92 delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 18, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order represents a task against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications, vaccines, and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience delivering both brand-name and generic pharmaceuticals across multiple therapeutic domains, positioning the company as a critical vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/17/25 |